Hegenbart U - Search Results

1

Search for AL amyloidosis risk factors using Mendelian randomization.

Saunders CN, Chattopadhyay S, Huhn S, Weinhold N, Hoffmann P, Nöthen MM, Jöckel KH, Schmidt B, Landi S, Goldschmidt H, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Schönland SO, Försti A, Houlston R, Hemminki K. Saunders CN, et al. Among authors: hegenbart u. Blood Adv. 2021 Jul 13;5(13):2725-2731. doi: 10.1182/bloodadvances.2021004423. Blood Adv. 2021. PMID: 34228109 Free PMC article.

2

[Gastrointestinal amyloidosis in IgG-kappa-light-chain plasmocytoma].

Hegenbart U, Goldschmidt H. Hegenbart U, et al. Dtsch Med Wochenschr. 1995 Aug 25;120(34-35):1187. Dtsch Med Wochenschr. 1995. PMID: 7656858 German. No abstract available.

3

[Paroxysmal nocturnal hemoglobinuria. Differentiation from other acquired hemolytic anemias and confirming the diagnosis].

Hegenbart U, Goldschmidt H. Hegenbart U, et al. Z Arztl Fortbild (Jena). 1994 Jan;88(1):59-62. Z Arztl Fortbild (Jena). 1994. PMID: 8154143 German. No abstract available.

4

Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Haas R, Hunstein W. Goldschmidt H, et al. Among authors: hegenbart u. Bone Marrow Transplant. 1996 May;17(5):691-7. Bone Marrow Transplant. 1996. PMID: 8733683 Clinical Trial.

5

Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Moos M, Eugenhart R, Wannenmacher M, Haas R, Hunstein W. Goldschmidt H, et al. Among authors: hegenbart u. Stem Cells. 1995 Dec;13 Suppl 3:36-41. doi: 10.1002/stem.5530130707. Stem Cells. 1995. PMID: 8747987 Clinical Trial.

6

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Ann Oncol. 1997 Mar;8(3):243-6. doi: 10.1023/a:1008252227512. Ann Oncol. 1997. PMID: 9137792 Free article. Clinical Trial.

7

Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Recent Results Cancer Res. 1998;144:27-35. doi: 10.1007/978-3-642-46836-0_4. Recent Results Cancer Res. 1998. PMID: 9304704

8

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Br J Haematol. 1997 Sep;98(3):736-44. doi: 10.1046/j.1365-2141.1997.2783095.x. Br J Haematol. 1997. PMID: 9332333 Free article.

9

High-dose chemotherapy in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Moos M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Leukemia. 1997 Dec;11 Suppl 5:S27-31. Leukemia. 1997. PMID: 9436935 Review.

10

Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatment.

Goldschmidt H, Salwender HJ, Hahn U, Hegenbart U, Egerer G, Wallmeier M, Jansen B, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Zentralbl Bakteriol. 1998 Jan;287(1-2):125-34. doi: 10.1016/s0934-8840(98)80158-8. Zentralbl Bakteriol. 1998. PMID: 9532271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page